Our drug discovery platform, called Redoxizyme^TM, develops diverse nanozymes continuously that mimic Prx.
These nanozymes can be applied to the treatment of various diseases, such as vascular, respiratory and neurodegenerative diseases and cancer,
depending on the status and expression of these enzymes.